X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year total asset growth rate
3Y CAGR
+27.8%/yr
Quarterly compound
Percentile
P89
Within normal range
vs 3Y Ago
2.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 77.59% |
| Q3 2025 | 55.52% |
| Q2 2025 | -19.11% |
| Q1 2025 | -11.22% |
| Q4 2024 | -17.80% |
| Q3 2024 | -15.41% |
| Q2 2024 | 87.74% |
| Q1 2024 | -23.82% |
| Q4 2023 | -15.02% |
| Q3 2023 | -0.06% |
| Q2 2023 | 39.38% |
| Q1 2023 | -20.04% |
| Q4 2022 | 37.19% |
| Q3 2022 | 39.97% |
| Q2 2022 | -18.68% |
| Q1 2022 | -14.98% |
| Q4 2021 | -2.77% |
| Q3 2021 | -14.92% |
| Q2 2021 | -12.03% |
| Q1 2021 | 31.06% |
| Q4 2020 | -7.70% |
| Q3 2020 | -6.60% |
| Q2 2020 | -7.28% |
| Q1 2020 | -4.34% |
| Q4 2019 | 46.71% |
| Q3 2019 | -17.95% |
| Q2 2019 | 113.44% |
| Q1 2019 | 73.73% |
| Q4 2018 | -21.56% |
| Q3 2018 | -19.77% |
| Q2 2018 | -17.35% |
| Q1 2018 | -14.81% |
| Q4 2017 | 118.65% |
| Q3 2017 | -5.96% |
| Q2 2017 | 260.07% |
| Q1 2017 | 44.33% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |